It is well established that a proportion of patients with tobacco amblyopia have pernicious anaemia or some other demonstrable defect of vitamin B12 metabolism (Leishman, 195I; Heaton, McCormick, and Freeman, I958; Freeman and Heaton, I96I; Foulds, Chisholm, Bronte-Stewart, and Wilson, I968). We have examined 65 cases of tobacco amblyopia diagnosed according to the criteria of Heaton and others (I958) for evidence of defective vitamin B12 metabolism, with particular reference to vitamin B12 absorption.
It was found impossible to estimate accurately the true dietary intake of vitamin B12, but evidence suggesting a poor intake was obtained in 25 per cent. of the amblyopes examined.
VITAMIN B12 ABSORPTION
Schilling tests were performed on 46 of the 65 amblyopes. Values of < 12 per cent. recovery were found in 2I (45. 7 per cent.) and of less than 5 per cent. in six ( 1 3 per cent.). Xylose absorption tests were carried out on 33 amblyopic patients and an abnormal result (i.e. < 3 g. per cert. in the urine) was found in six patients (i8 per cent.) while border-line figures (3 to 4 g. per cent. in the urine) were found in a further three (9 per cent.).
VITAMIN B12 IN RELATION TO TOBACCO CONSUMPTION
In an attempt to determine whether the low level of serum B12 found in 40 per cent. of the tobacco amblyopes was the resultof tobacco smoking or an independentlydetermined factor, the tobacco consumption in these patients was plotted against the serum B12 level (Fig. i) , when it could be seen that there was a significant though not very close positive correlation between these factors (r = +o0384; n =53, P = <oOI). In this group of patients tobacco amblyopia occurred with a low consumption of tobacco, where the serum B12 level was low, a much higher consumption of tobacco being the rule when the serum B12 level was in the normal range. A similar trend was noted in the case of tobacco consumption and the results of the Schilling test in these patients (Fig. 2) where poor absorption of B12 tended to be associated with low levels of tobacco consumption and vice versa. The correlation is less close than for serum B12 (r = +o0330), but is significant (n =40; P = <0.o05) Surprisingly, a similar trend was noted when the results of the xylose absorption tests in tobacco amblyopes were compared with tobacco consumption (Fig. 3, opposite) . The correlation coefficient in this instance however, was only +-O234, which fails to be significant (P=->o IO).
To test whether the relationship between tobacco consumption and serum B12 level was common to all smokers or only amblyopes, a comparison was made between the tobacco consumption and serum B12 level of 28 male non-amblyopic pipe smokers of similar age to the amblyopic patients (mean 64-9 years, range 43-82) ( One additional comparison was made. The mean serum B12 level in a group of nonsmoking patients was compared with that of pipe-smoking non-amblyopic subjects. Both groups were drawn from a hospital population and consisted of patients in the same age range as the tobacco amblyopes who were attending hospital with eye conditions other than tobacco amblyopia. In the non-smoking group there were 43 subjects and in the pipe smoking group 28 subjects. The mean serum B12 level in the former group was 228 yug./ml. + i I6, and in the latter 269-5 u9g./ml. + ioi. There is no significant difference in the mean serum B12 levels of the two groups ("t" = I'55; n =67; P = >O I). The mean serum B12 level in the pipe-smoking control group is however significantly greater than in the group of patients with tobacco amblyopia ("t" = 2-79; n =8I; P = <o-oi). The consumption of tobacco in the group of non-amblyopic pipe smokers was not significantly different from that of the amblyopic group of patients (mean tobacco consumption of the control group 2.73 oz. per week + I 32 and of the amblyopic group 3o04oz. perweek + ±I44; "t" =o 3o; n =8i; P = >o I).
Discussion
From our results tobacco amblyopia is a condition which most readily develops in patients whose dietary B12 or B12 absorption is for some reason defective and in such patients amblyopia may develop even when the consumption of tobacco is only moderate (< IO cigarettes per day in one ofour patients). Patients with normal B12 absorption and normal levels of B12 in the serum may also develop amblyopia if they smoke heavily enough. These facts would fit the suggestion that tobacco amblyopia is the result of a failure to detoxify cyanide derived from tobacco smoke (Wokes, 1958; Smith, I961) and that B12, particularly in its hydroxy form, is necessary for this detoxification (Smith, I968) . If this is true then it is not suprising that smoking patients with low serum B12 levels due to dietary lack or malabsorption of B12 should develop this disease, or that there should be a direct relationship between the amount of tobacco required to induce this condition and the amount of available B12. That patients with normal serum B12 levels should also develop amblyopia if their tobacco consumption is high enough, might be explained as suggested by Smith (I96I) that in such patients much of the available B12 has been converted to cyanocobalamin and is therefore unable to detoxify further cyanide, or that as cyanocobalamin it is unable to support certain aspects of optic nerve metabolism.
It is known that patients with tobacco amblyopia, whether overtly B12 deficient or not, recover vision on treatment with hydroxocobalamin ( and not cyanocobalamin) even if smoking is continued (Chisholm, and Foulds, I967) , and from this alone it is evident that in these patients, although there may be no apparent B12 deficiency, there must be a relative deficiency of B12, or of some B12 fraction.
The development of tobacco amblyopia, however, cannot be merely the consequence of a high cyanide intake in the presence of B12 depletion for the correlation between tobacco intake and serum B12 levels is not very close. In addition we have examined several patients with pernicious anaemia who are also heavy smokers and who have shown no discoverable disturbance of visual function. If B12 deficiency and heavy tobacco consumption were the sole factors in the production of amblyopia, such patients would inevitably develop the condition.
It has been suggested that tobacco consumption itself may depress B12 absorption, Leishman (1951) suggesting that swallowed products of pipe smoking might inhibit gastric secretion while more recently Phillips and Ainley (1968) have claimed that tobacco smoking depresses B12 absorption as shown by the Schilling test. Our results do not support these views. We have found no difference in the serum B12 levels of smoking and non-smoking subjects and no correlation could be demonstrated between tobacco intake and serum B12 level in healthy pipe smokers. In amblyopic patients on the contrary, both B1 2 absorption and serum levels varied directly with tobacco consumption, the reverse of what would be expected had tobacco intake been a significant factor in depressing B12 absorption. From our results it would appear that a depressed absorption of B12 as shown by the Schilling test or by low levels of B12 in the serum, is an independently determined factor which is nevertheless of aetiological significance in relation to the development ofamblyopia. The trend towards a correlation between intestinal absorption, as shown by the xylose absorption test, and tobacco consumption in patients with tobacco amblyopia is comparable to the results of the Schilling test, the xylose absorption test in this instance probably giving a mezsure of intestinal absorption of B12, particularly in those patients whose faulty B12 absorption is not due to a specific defect such as Addisonian pernicious anaemia.
Summary
Schilling tests of vitamin B12 absorption, xylose tests of intestinal absorption, and measurements of serum vitamin B12 were carried out in a group of 65 patients suffering from tobacco amblyopia. Serum vitamin B12 estimations were also made on a group of nonamblyopic pipe-smoking patients and in a similar group of non-smoking patients.
40 per cent. of tobacco amblyopes showed reduced serum levels of vitamin B12 and 45 per cent. had defective vitamin B12 absorption. Serum vitamin B12 levels in tobacco amblyopes were significantly lower than in non-amblyopic subjects. Serum vitamin B12 levels were similar in non-amblyopic smokers and non-smokers. In tobacco amblyopia a direct relationship was found to exist between tobacco consumption on the one hand and vitamin B12 absorption and serum vitamin B12 level on the other, amblyopia occurring with low tobacco consumption where vitamin B12 absorption was poor or the serum vitamin B12 level low, a high consumption being necessary where the serum vitamin B12 level was high.
The significance of the findings is discussed in relation to the aetiology of tobacco amblyopia.
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